These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

969 related items for PubMed ID: 12700710

  • 21. Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test.
    Young JW, Meves JM, Geyer MA.
    Behav Brain Res; 2013 Mar 01; 240():119-33. PubMed ID: 23201359
    [Abstract] [Full Text] [Related]

  • 22. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
    Schneider JS, Tinker JP, Van Velson M, Menzaghi F, Lloyd GK.
    J Pharmacol Exp Ther; 1999 Aug 01; 290(2):731-9. PubMed ID: 10411585
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
    Masuoka T, Kamei C.
    Psychopharmacology (Berl); 2009 Oct 01; 206(2):259-65. PubMed ID: 19639304
    [Abstract] [Full Text] [Related]

  • 28. Nicotinic receptor subtypes and cognitive function.
    Levin ED.
    J Neurobiol; 2002 Dec 01; 53(4):633-40. PubMed ID: 12436426
    [Abstract] [Full Text] [Related]

  • 29. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Cosford ND.
    Brain Res; 2008 Oct 09; 1234():16-24. PubMed ID: 18692487
    [Abstract] [Full Text] [Related]

  • 30. Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.
    Braida D, Ponzoni L, Martucci R, Sparatore F, Gotti C, Sala M.
    Psychopharmacology (Berl); 2014 May 09; 231(9):1975-85. PubMed ID: 24311357
    [Abstract] [Full Text] [Related]

  • 31. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC, O'Neill HC, Marks MJ, Grady SR.
    Nicotine Tob Res; 2012 Jun 09; 14(6):711-9. PubMed ID: 22241831
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.
    Howe WM, Ji J, Parikh V, Williams S, Mocaër E, Trocmé-Thibierge C, Sarter M.
    Neuropsychopharmacology; 2010 May 09; 35(6):1391-401. PubMed ID: 20147893
    [Abstract] [Full Text] [Related]

  • 33. Role of mouse cerebellar nicotinic acetylcholine receptor (nAChR) α(4)β(2)- and α(7) subtypes in the behavioral cross-tolerance between nicotine and ethanol-induced ataxia.
    Taslim N, Soderstrom K, Dar MS.
    Behav Brain Res; 2011 Mar 01; 217(2):282-92. PubMed ID: 20974182
    [Abstract] [Full Text] [Related]

  • 34. Hippocampal long term memory: effect of the cholinergic system on local protein synthesis.
    Lana D, Cerbai F, Di Russo J, Boscaro F, Giannetti A, Petkova-Kirova P, Pugliese AM, Giovannini MG.
    Neurobiol Learn Mem; 2013 Nov 01; 106():246-57. PubMed ID: 24076274
    [Abstract] [Full Text] [Related]

  • 35. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents.
    Lloyd GK, Menzaghi F, Bontempi B, Suto C, Siegel R, Akong M, Stauderman K, Velicelebi G, Johnson E, Harpold MM, Rao TS, Sacaan AI, Chavez-Noriega LE, Washburn MS, Vernier JM, Cosford ND, McDonald LA.
    Life Sci; 1998 Nov 01; 62(17-18):1601-6. PubMed ID: 9585143
    [Abstract] [Full Text] [Related]

  • 36. Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells.
    Das JR, Tizabi Y.
    Neurotox Res; 2009 Oct 01; 16(3):194-204. PubMed ID: 19526284
    [Abstract] [Full Text] [Related]

  • 37. Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands.
    Grottick AJ, Haman M, Wyler R, Higgins GA.
    Neuropsychopharmacology; 2003 May 01; 28(5):880-7. PubMed ID: 12637951
    [Abstract] [Full Text] [Related]

  • 38. Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats.
    Gawel K, Labuz K, Jenda M, Silberring J, Kotlinska JH.
    Behav Brain Res; 2014 Jul 15; 268():169-76. PubMed ID: 24755308
    [Abstract] [Full Text] [Related]

  • 39. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder.
    Ueno K, Togashi H, Matsumoto M, Ohashi S, Saito H, Yoshioka M.
    J Pharmacol Exp Ther; 2002 Jul 15; 302(1):95-100. PubMed ID: 12065705
    [Abstract] [Full Text] [Related]

  • 40. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A, Nazari-Serenjeh F, Zarrindast MR, Sepehri H, Delphi L.
    Eur J Pharmacol; 2007 May 07; 562(1-2):92-102. PubMed ID: 17336285
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.